Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 35 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10654802

    Indoline derivatives and method for using and producing the same

    Arizona Board of Regents on Behalf of the University · Granted May 19, 2020 · Expires May 14, 2040

    granted
  2. US 10653150

    Shelf life and color profile of resin compositions with silver nanoparticles

    The Board of Regents of the University of Texas System · Granted May 19, 2020 · Expires May 14, 2040

    granted
  3. US 10653743

    Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 19, 2020 · Expires May 14, 2040

    granted
  4. US 10646438

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted May 12, 2020 · Expires May 7, 2040

    granted
  5. US 10647964

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 12, 2020 · Expires May 7, 2040

    granted
  6. US 10646574

    Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

    The Board of Regents of the University of Texas System · Granted May 12, 2020 · Expires May 7, 2040

    granted
  7. US 10639277

    Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma

    The Board of Regents of the University of Texas System · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  8. US 10640535

    Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

    The Board of Regents of the University of Oklahoma · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  9. US 10633411

    Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  10. US 10633657

    Methods for treatment of polycystic kidney disease

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  11. US 10633445

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  12. US 10633442

    Antibodies to connexin 43 (Cx43) hemichannels and methods of use thereof to inhibit Cx43 hemichannel opening

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  13. US 10633643

    Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  14. US 10633363

    EPAC1 activators as HIV latency reversal agents (LRA)

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  15. US 10626469

    Rapid identification of microorganisms

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  16. US 10626087

    Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same

    The Board of Regents of the University of Texas System · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted
  17. US 10617709

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  18. US 10620204

    Antibody-mediated neutralization of Ebola viruses

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  19. US 10617681

    1-arylalkyl-4-acylaminopiperidine compounds

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  20. US 10618869

    Oligo-benzamide compounds and their use

    The Board of Regents of the University of Texas System · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  21. US 10604501

    Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  22. US 10603311

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  23. US 10598665

    Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

    The Board of Regents of the University of Texas System · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  24. US 10596247

    Methods and compositions for attenuated chlamydia as vaccine and vector

    The Board of Regents of the University of Texas System · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted